Lexaria Bioscience Corp. announced that its has appointed Allan Spissinger as new acting CFO, Secretary and Treasurer. Allan Spissinger was involved in the information technologies (IT) sector for more than 10 years working on corporate IT infrastructure and software development projects before focusing on finance and accounting.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.92 USD | -7.30% | -8.18% | +133.60% |
May. 17 | Lexaria Bioscience Corp. Announces Dosing Begins in Comprehensive GLP-1 Animal Study | CI |
May. 08 | Lexaria Bioscience Corp. Begins Dosing of Its Second Glp-1 Human Pilot Study | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+133.60% | 40.59M | |
+34.35% | 693B | |
+29.39% | 584B | |
-3.49% | 372B | |
+20.15% | 332B | |
+6.19% | 294B | |
+14.11% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+9.21% | 168B |
- Stock Market
- Equities
- LEXX Stock
- News Lexaria Bioscience Corp.
- Lexaria Bioscience Corp Appoints Allan Spissinger as New Acting CFO, Secretary and Treasurer